Skip to main content

Palo Alto Investors LP

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1306923 PALO ALTO, CA

Position in XERS

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$826,927
+$221,349 QoQ
Shares Held
104,410
0.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#94
of 238 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Palo Alto Investors LP holds $50,502,024 across 4 Drug Manufacturers - Specialty & Generic names. XERS ranks #4 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 XERS
Xeris Biopharma Holdings, Inc.
This page
104,410 $826,927

All Filings in XERS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $826,927 104,410
2026-03-31 $605,578 104,410